Evicenter
Leqvio (inclisiran) in Hypercholesterolemia
Manufacturer
Novartis Pharmaceuticals Corporation
Prescribing information
Leqvio (opens in a new tab)
Questions
17
Last updated

All questions

Clinical trials: Leqvio (inclisiran) in hypercholesterolemia

9 questions · 5 sources

Cardiovascular outcomes

Does Leqvio reduce heart attacks, strokes, or cardiovascular deaths?

Note: This sentence appears on the guidelines and unmet-need pages of the Leqvio HCP site, as captured on November 14, 2026. The Prescribing Information (revised 08/2026) does not include it.

Study results

How much does Leqvio lower LDL-C vs placebo in ASCVD (ORION-10)?

Does Leqvio lower ApoB and non-HDL cholesterol (ORION-10)?

Note: Table 2 gives the placebo row, the LEQVIO row, and the difference from placebo (LS mean, 95% CI), each in the column order LDL-C, total cholesterol, non-HDL-C, and ApoB; values are mean percentage change from baseline to Day 510.

How many patients reached LDL-C below 70 mg/dL on Leqvio (ORION-10)?

Note: The trial targets are those defined in the footnote; the Leqvio HCP site states that they align with the 2018 AHA/ACC cholesterol guideline. The site gives the 2026 guideline targets separately (see the question on the 2026 guideline LDL-C targets).

How much did Leqvio lower LDL-C vs placebo in ORION-11?

Note: The trial targets are those defined in the footnote; the Leqvio HCP site states that they align with the 2018 AHA/ACC cholesterol guideline. The site gives the 2026 guideline targets separately (see the question on the 2026 guideline LDL-C targets).

Does Leqvio lower LDL-C after acute coronary syndrome vs usual care (V-INCEPTION)?

Note: The page cites a presentation at the National Lipid Association 2025 Scientific Sessions for V-INCEPTION.

Did early Leqvio reduce statin discontinuation vs usual care (V-INITIATE)?

Note: The page presents the V-INITIATE LDL-C results as graphics, so they are not quoted.

Subgroup results

Does Leqvio lower LDL-C similarly across age, sex, and diabetes subgroups?

Note: Trial 1 is ORION-10 and Trial 2 is ORION-11 in the Prescribing Information.

Long-term results

How well does Leqvio lower LDL-C long term (ORION-8 extension)?

Note: ORION-8 included patients from ORION-9, which the Prescribing Information describes as a trial in adults with HeFH.